Related Experiment Video
Updated: Jul 11, 2025

Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device
Published on: September 24, 2020
SARS-CoV-2 pneumonia and Eisenmenger's syndrome: doubling the challenge
Paola Pierucci1, Lucrezia De Michele2, Maria Luisa De Candia1
1Respiratory and Critical Care Unit, Cardiothoracic Department, Bari Policlinic University Hospital; Section of Respiratory Diseases, Department of Basic Medical Science Neuroscience and Sense Organs, University of Bari "Aldo Moro".
Abstract:
Eisenmenger's syndrome (ES) is the most severe phenotype of pulmonary arterial hypertension secondary to congenital heart disease. In these cases, significant systemic-to-pulmonary (left-to-right) shunting triggers the development of pulmonary vascular disease and pulmonary hypertension. In cases of acute hypoxemic respiratory failure in patients with ES, high-flow nasal cannula (HFNC) oxygen therapy should be considered as a first-line approach in order to avoid pulmonary complications and right ventricular overload related to positive pressure ventilation. Here, we report a case of HFNC use in a patient with COVID-19 infection and ES.
Related Concept Videos
Pulmonary Embolism I: Introduction
Pneumonia III: Complications and Assessment
Pneumonia II: Pathophysiology
Acute Coronary Syndrome V: Nursing Management
Acute Respiratory Failure-II
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
Acute Respiratory Failure-III

